OmniVis
 | This article, OmniVis, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Comment: Remove all non-notable awards to start with. Nomadicghumakkad (talk) 20:44, 1 November 2021 (UTC)
OmniVis is a US-based company that specialises in rapid medical diagnostic tests.[1]
| Founded | 2017 |
|---|---|
| Headquarters | San Francisco, California, USA |
Key people | Katherine Clayton, CEO |
| Website | www.omnivistech.com |
Products
OmniTech (Cholera test)
OmniTech rapid Cholera detection device can identify the presence of Vibrio cholerae in water in approximately 30 minutes.[1] OmniTech uses a process of DNA amplification and viscosity measurement[2], it costs approximately US$10 per test.[2] The processing is done on an Android smartphone[2] that analyses water samples that are put into a single use test kit element.[1]
The current design is not well suited for large scale testing due to the small volume that can be tested.[1]
COVID-19 rapid diagnostic test
In May 2020 OmniVis was working on the early stages of a rapid test for COVID-19[3] that detects the disease in human saliva[4]. The rapid tests uses a smartphone for processing.[3]
Key People
Katherine Clayton PhD, Founder & CEO[1]
References
- ^ a b c d e "This Handy New Device Might Help KO Cholera". NPR.org. 7 Aug 2019. Retrieved 2021-10-31.
- ^ a b c "OmniVis could save lives by detecting cholera-infected water in minutes rather than days". TechCrunch. Retrieved 2021-10-31.
- ^ a b Marcus, Brianna Abbott and Amy Dockser (2020-05-26). "Race Is On to Create Rapid Covid-19 Tests for the Fall". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-10-31.
- ^ "People Behind CSR at Cisco: Early-stage tech entrepreneurs get a boost from Cisco's Global Problem Solver Challenge". Cisco Blogs. 2021-10-12. Retrieved 2021-10-31.